Boholamide A, an APD-Class, Hypoxia-Selective Cyclodepsipeptide
Joshua P. Torres(University of Utah), Eric W. Schmidt(University of Utah), Lee U. Leavitt(University of Utah), Changshan Niu(University of Utah), David S. Fenton(University of Utah), Zhenjian Lin(University of Utah), Randall T. Peterson(University of Utah), Gisela P. Concepción(University of the Philippines Diliman), Pui‐Ying Lam(University of Utah), Baldomero M. Olivera(University of Utah), Jose Miguel D. Robes(University of the Philippines Diliman), Margo G. Haygood(University of Utah)
Cited by 17
Related Papers
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k
In vivo drug discovery in the zebrafish
|Nature Reviews Drug Discovery|2005|1.4k
New developments in RiPP discovery, enzymology and engineering
|Natural Product Reports|2020|793
Targeted gene disruption in somatic zebrafish cells using engineered TALENs
|Nature Biotechnology|2011|628